HEM Pharma participated in IPC 2026, held in Kraków, Poland. IPC (International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health) is a global conference where researchers and industry professionals gather to share the latest scientific findings and industry trends in probiotics, prebiotics, and the gut microbiome.

At the conference, HEM Pharma introduced its proprietary PMAS (Personalized Pharmaceutical Meta-Analysis Screening) technology, highlighting its approach to personalized microbiome research and its potential applications in precision healthcare.

HEM Pharma will continue to participate in international scientific conferences and strengthen global research collaborations to advance microbiome-based healthcare technologies.

Global food and nutrition industry publication NutraIngredients featured an article during IPC 2026 highlighting HEM Pharma's PMAS technology and collaborative research. The article introduces the company's research approach and explores the potential of microbiome-based technologies.

Read the article >>

https://www.nutraingredients.com/Article/2026/06/29/probioticphytonutrient-blends-may-boost-bowel-function-and-other-gut-health-measures/